Read news on Evolocumab with our app.
Read more in the app
Evolocumab to reduce first major cardiovascular events in patients without known significant atherosclerosis and with diabetes - EurekAlert!
Evolocumab did not improve vein graft disease following coronary artery bypass surgery - EurekAlert!
